UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 177

Sortiert nach

High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients

Therapeutic advances in neurological disorders, 2021, Vol.14, p.1756286421998915-1756286421998915

2021

Volltextzugriff (PDF)

The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis

Therapeutic advances in neurological disorders, 2019-07, Vol.12, p.1756286419859183-1756286419859183

2019

Volltextzugriff (PDF)

A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomes

Therapeutic advances in neurological disorders, 2023-01, Vol.16, p.17562864231197994-17562864231197994

2023

Volltextzugriff (PDF)

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe

Therapeutic advances in neurological disorders, 2023-01, Vol.16, p.17562864231198963-17562864231198963

2023

Volltextzugriff (PDF)

The MSBase pregnancy, neonatal outcomes, and women’s health registry

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211009104-17562864211009104

2021

Volltextzugriff (PDF)

Addressing the treatment gap in MS-associated tremor: A new door opens

Multiple sclerosis, 2020-06, Vol.26 (7), p.858-858

van der Walt, Anneke

2020

Volltextzugriff (PDF)

021 Relationships between Cognitive Impairment and Clinical Features of Idiopathic Intracranial Hypertension

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A8-A9

2021

Volltextzugriff (PDF)

011 Worsening longitudinal reaction time trajectories using the MSReactor computerised battery predicts confirmed EDSS progression

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A5-A5

2021

Volltextzugriff (PDF)

010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A4-A5

2021

Volltextzugriff (PDF)

100 Developing a quality assurance framework for neuro-ophthalmology referrals using NODE – the neuro-ophthalmology database

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A36-A36

2021

Volltextzugriff (PDF)

008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A4-A4

2021

Volltextzugriff (PDF)

Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

Journal of neuroimmunology, 2021-08, Vol.357, p.577627-577627, Article 577627

2021

Volltextzugriff (PDF)

Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis

Multiple sclerosis, 2023-04, Vol.29 (4-5), p.540-548

2023

Volltextzugriff (PDF)

The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis

Neurotherapeutics, 2020-10, Vol.17 (4), p.1768-1784

2020

Volltextzugriff (PDF)

Serial Diffusion Tensor Imaging of the Optic Radiations after Acute Optic Neuritis

Journal of Ophthalmology, 2016-01, Vol.2016, p.2764538-6

2016

Volltextzugriff (PDF)

004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A2-A2

2021

Volltextzugriff (PDF)

The characteristics and reproducibility of motor speech functional neuroimaging in healthy controls

Frontiers in human neuroscience, 2024-08, Vol.18

2024

Volltextzugriff (PDF)

Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis

Scientific reports, 2024-01, Vol.14 (1), p.1436-1436, Article 1436

2024

Volltextzugriff (PDF)

Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force

Multiple sclerosis, 2024-03, Vol.30 (3), p.396-418

2024

Volltextzugriff (PDF)

Prediction of relapse activity when switching to cladribine for multiple sclerosis

Multiple sclerosis, 2023-01, Vol.29 (1), p.119-129

2023

Volltextzugriff (PDF)

Gait stability reflects motor tracts damage at early stages of multiple sclerosis

Multiple sclerosis, 2022-10, Vol.28 (11), p.1773-1782

2022

Volltextzugriff (PDF)

Disease Delineation for Multiple Sclerosis, Friedreich Ataxia, and Healthy Controls Using Supervised Machine Learning on Speech Acoustics

IEEE transactions on neural systems and rehabilitation engineering, 2023, Vol.31, p.4278-4285

2023

Volltextzugriff (PDF)

Fibre-specific white matter changes in multiple sclerosis patients with optic neuritis

NeuroImage clinical, 2018-01, Vol.17, p.60-68

2018

Volltextzugriff (PDF)

Prediction of multiple sclerosis outcomes when switching to ocrelizumab

Multiple sclerosis, 2022-05, Vol.28 (6), p.958-969

2022

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(164)

Publikationsform

Sprache

Englisch
(177)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(117)
Multiple Sclerosis
(111)
Neurosciences & Neurology
(96)
Clinical Neurology
(86)
Humans
(77)
Neurosciences
(56)
Female
(42)
Male
(36)
Adult
(35)
Neurology
(32)
Middle Aged
(24)
Patients
(21)
Magnetic Resonance Imaging
(19)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(17)
Multiple Sclerosis - Complications
(16)
Multiple Sclerosis - Drug Therapy
(15)
Registries
(14)
Disability Evaluation
(11)
Hospitals
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients

The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis

A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomes

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe

The MSBase pregnancy, neonatal outcomes, and women’s health registry

Addressing the treatment gap in MS-associated tremor: A new door opens

021 Relationships between Cognitive Impairment and Clinical Features of Idiopathic Intracranial Hypertension

011 Worsening longitudinal reaction time trajectories using the MSReactor computerised battery predicts confirmed EDSS progression

010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort

100 Developing a quality assurance framework for neuro-ophthalmology referrals using NODE – the neuro-ophthalmology database

008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis

Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis

The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis

Serial Diffusion Tensor Imaging of the Optic Radiations after Acute Optic Neuritis

004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis

The characteristics and reproducibility of motor speech functional neuroimaging in healthy controls

Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis

Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force

Prediction of relapse activity when switching to cladribine for multiple sclerosis

Gait stability reflects motor tracts damage at early stages of multiple sclerosis

Disease Delineation for Multiple Sclerosis, Friedreich Ataxia, and Healthy Controls Using Supervised Machine Learning on Speech Acoustics

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry

Fibre-specific white matter changes in multiple sclerosis patients with optic neuritis

Prediction of multiple sclerosis outcomes when switching to ocrelizumab

Suchergebnisse filtern